4.7 Article

Predicting survival in women with breast cancer and brain metastasis A nomogram outperforms current survival prediction models

Related references

Note: Only part of the references are listed.
Article Oncology

Nomogram predicting clinical outcomes in breast cancer patients treated with neoadjuvant chemotherapy

Bhumsuk Keam et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)

Review Oncology

Brain metastases in HER2-positive breast cancer: The evolving role of lapatinib

Gianluca Tomasello et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2010)

Meeting Abstract Oncology

A graded prognostic assessment (GPA) for women with breast cancer and brain metastases.

P. W. Sperduto et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

Article Oncology

Nomogram to Predict Subsequent Brain Metastasis in Patients With Metastatic Breast Cancer

Olivier Graesslin et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

Article Oncology

Metastatic Behavior of Breast Cancer Subtypes

Hagen Kennecke et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

Article Oncology

How to build and interpret a nomogram for cancer prognosis

Alexia Iasonos et al.

JOURNAL OF CLINICAL ONCOLOGY (2008)

Article Urology & Nephrology

Predicting an optimal outcome after radical prostatectomy: The trifecta nomogram

James A. Eastham et al.

JOURNAL OF UROLOGY (2008)

Review Oncology

An overview of prognostic factors for long-term survivors of breast cancer

Isabelle Soerjomataram et al.

BREAST CANCER RESEARCH AND TREATMENT (2008)

Article Oncology

Global cancer statistics, 2002

DM Parkin et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2005)

Review Oncology

CNS metastases in breast cancer

NU Lin et al.

JOURNAL OF CLINICAL ONCOLOGY (2004)

Article Oncology

Breast cancer incidence and mortality trends in 16 European countries

JL Botha et al.

EUROPEAN JOURNAL OF CANCER (2003)

Article Oncology

Results of whole brain radiotherapy in patients with brain metastases from breast cancer: A retrospective study

AS Mahmoud-Ahmed et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)

Article Medicine, General & Internal

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

DJ Slamon et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)